Rob Surgical opens its new plant to boost the expansion of the Bitrack robot in Europe

 

The Minister of Industry and Tourism, Jordi Hereu, has inaugurated the new production plant of Rob Surgical en El Prat de LlobregatThis strategic infrastructure, designed to manufacture the surgical robot. BitrackIt integrates the entire production process to supply the market of Europa once the CE marking regulatory process is completed.

 

Industrial landmark with an export focus

 

The event was attended by a wide range of institutional and business representatives, including the Secretary of State for Industry, Jordi Garcia Brustenga, the Government Delegate in Cataluña, Carlos Prieto, as well as local authorities such as the mayor Alba BouOn behalf of the company, they have acted as hosts Jaume Amat, co-founder and board member, and Mario FerradosaManaging Director.

 

The commissioning of this 500 m² facility not only symbolizes the technological consolidation of Rob Surgicalbut activates a ambitious financial roadmapThe company anticipates an investment of 50 millones de euros in the coming years to execute the commercial launch, scale up industrialization and expand the portfolio of instruments.

 

Below are the details key figures of the industrial project:

 

Concept	Project Data
Plant area	500m²
Initial production capacity	15-20 robots/year
Investment forecast	50 millones de euros
Human capital	55 current employees (projected to reach 200 in 5 years)
Target market	España y Unión Europea

 

Bitrack Technology: Precision and access to the European market

 

The system Bitrack It positions itself as a state-of-the-art robotic platform for minimally invasive surgeryIts value proposition lies in its ability to integrate into existing operating rooms, enabling hybrid procedures in both high-volume hospitals and centers with limited access to traditional robotics.

 

Currently, the robot is in the final phase of obtaining CE marking, an essential requirement for its sale in the Unión EuropeaThe technology is focused on soft tissue interventions in the abdominal area, covering critical specialties such as:

 

• Urology.
• Gynecology.
• Gastroenterology.

 

Furthermore, Rob Surgical has strengthened its technological ecosystem through strategic agreements, including its recent collaboration with DFactoryconsolidating its B2B business model in the sector MedTech.

 

New governance for international expansion

 

The opening coincides with a strengthening of the firm's management structure. From July 2025, Mario Ferradosa He leads the company by contributing his experience in international markets. Ferradosa He emphasized that this opening is "a fundamental step to integrate the industrial process of Bitrack in the period prior to its entry into the market".

 

For his part, the co-founder Jaume Amat He emphasized the importance of maintaining industrial sovereignty: "Having our own manufacturing plant exemplifies the volu"We are committed to building a high value-added project with local roots and an international outlook.".

 

The minister Jordi Hereu He closed the event by emphasizing the value of technological reindustrialization: «Rob Surgical is an example of the technology industry that España y Europa They need: demanding, with high added value and at the service of health as a universal right.".

 

Key points and frequently asked questions about Rob Surgical and Bitrack

What is the Bitrack system and what is it used for?
It is a surgical robot designed by Rob Surgical for performing minimally invasive surgeries with high precision. It specializes in soft tissue surgery for urology, gynecology, and gastroenterology, and allows for hybrid procedures to be performed in real clinical settings.

What is the capacity of the new plant in El Prat?
The 500 m² plant has an initial capacity to manufacture between 15 and 20 robots per year. This infrastructure will allow the company to scale its production to meet European demand once it obtains regulatory approvals.

What commercial stage is the project in?
Bitrack It is in the final phase for obtaining the CE marking, necessary to market it in the Unión EuropeaThe company plans to invest 50 million euros in the coming years to support its launch and international expansion.